SCHEMBL8934614

SCHEMBL8934614

COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2cc1OC

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.74
CYP3A4 P08684 7/20 0.74
CYP2C19 P33261 6/20 0.74
ALDH1A1 P00352 6/20 0.74
CYP2C9 P11712 5/20 0.74
HPGD P15428 5/20 0.74
HSD17B10 Q99714 5/20 0.74
TP53 P04637 6/20 0.71
MAPT P10636 6/20 0.71
MEN1 O00255 5/20 0.71
KMT2A Q03164 5/20 0.71
CYP2D6 P10635 4/20 0.71
FYN P06241 1/20 0.70
MAPK1 P28482 2/20 0.69
TSHR P16473 1/20 0.69
PPARG P37231 1/20 0.69
POLB P06746 2/20 0.66
CSNK2A2 P19784 2/20 0.65
CSNK2B P67870 2/20 0.65
CSNK2A1 P68400 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31552889 0.87 ALDH1A1 (0.76) KDM4ECYP3A4CYP2C19ALDH1A1CYP2C9
SCHEMBL8934505 0.86 CYP1A1 (0.69) KDM4ECYP3A4CYP2C19ALDH1A1CYP2C9
SCHEMBL10068612 0.86 CSNK2A2 (0.69) KDM4ECYP3A4CYP2C19ALDH1A1CYP2C9
SCHEMBL4650049 0.85 KDM4E (1.00) KDM4ECYP3A4CYP2C19ALDH1A1CYP2C9
SCHEMBL31527819 0.85 KDM4E (1.00) KDM4ECYP3A4CYP2C19ALDH1A1CYP2C9
SCHEMBL25204150 0.85 KDM4E (0.73) KDM4ECYP3A4CYP2C19ALDH1A1CYP2C9
SCHEMBL29999985 0.84 TNKS (0.69) KDM4ECYP3A4CYP2C19ALDH1A1CYP2C9
SCHEMBL30266579 0.83 CYP3A4 (1.00) KDM4ECYP3A4CYP2C19ALDH1A1CYP2C9
SCHEMBL312254 0.83 CYP3A4 (1.00) KDM4ECYP3A4CYP2C19ALDH1A1CYP2C9
SCHEMBL8934506 0.82 TUBB4A (0.79) KDM4ECYP3A4CYP2C19ALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO claimed